Works by WAN Min

Results: 384
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Efficacy and safety of a fixed‐dose combination of dapagliflozin and linagliptin (AJU‐A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, parallel‐group, placebo‐controlled phase III study

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 81, doi. 10.1111/dom.15985
    By:
    • Hong, Jun Hwa;
    • Kim, Myung Jin;
    • Min, Kyung Wan;
    • Won, Jong Chul;
    • Kim, Tae Nyun;
    • Lee, Byung‐Wan;
    • Kang, Jun Goo;
    • Kim, Jae Hyeon;
    • Park, Jung Hwan;
    • Ku, Bon Jeong;
    • Lee, Chang Beom;
    • Kim, Sang Yong;
    • Shon, Ho Sang;
    • Lee, Woo Je;
    • Park, Joong‐Yeol
    Publication type:
    Article
    14

    A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2188, doi. 10.1111/dom.15526
    By:
    • Lim, Soo;
    • Lee, Seung‐Hwan;
    • Min, Kyung‐Wan;
    • Lee, Chang Beom;
    • Kim, Sang Yong;
    • Yoo, Hye Jin;
    • Kim, Nan Hee;
    • Kim, Jae Hyeon;
    • Oh, Seungjoon;
    • Won, Jong Chul;
    • Kwon, Hyuk Sang;
    • Kim, Mi Kyung;
    • Park, Jung Hwan;
    • Jeong, In‐Kyung;
    • Kim, Sungrae
    Publication type:
    Article
    15

    Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2743, doi. 10.1111/dom.15164
    By:
    • Park, Hyeong Kyu;
    • Kim, Kyoung‐Ah;
    • Min, Kyung‐Wan;
    • Sohn, Tae‐Seo;
    • Jeong, In Kyung;
    • Ahn, Chul Woo;
    • Kim, Nan‐Hee;
    • Park, Ie Byung;
    • Cho, Ho Chan;
    • Chung, Choon Hee;
    • Choi, Sung Hee;
    • Park, Kang Seo;
    • Yang, Seoung‐Oh;
    • Lee, Kwan Woo
    Publication type:
    Article
    16

    Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase 2 trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2096, doi. 10.1111/dom.15080
    By:
    • Yang, Ye Seul;
    • Min, Kyung Wan;
    • Park, Seok‐O;
    • Kim, Kyung‐Soo;
    • Yu, Jae Myung;
    • Hong, Eun‐Gyoung;
    • Cho, Sung Rae;
    • Won, Kyu Chang;
    • Kim, Yong Hyun;
    • Oh, Seungjoon;
    • Choi, Sung Hee;
    • Koh, Gwanpyo;
    • Huh, Wan;
    • Kim, Su Young;
    • Park, Kyong Soo
    Publication type:
    Article
    17
    18

    A 52‐week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add‐on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1535, doi. 10.1111/dom.13256
    By:
    • for the Gemigliptin Study 006 Group;
    • Jung, Chan‐Hee;
    • Rhee, Eun‐Jung;
    • Lee, Won‐Young;
    • Min, Kyung Wan;
    • Shivane, Vyankatesh K.;
    • Sosale, Aravind R.;
    • Jang, Hak Chul;
    • Chung, Choon Hee;
    • Nam‐Goong, Il Seong
    Publication type:
    Article
    19
    20
    21
    22
    23

    Safety and Efficacy of Modern Insulin Analogues.

    Published in:
    Diabetes & Metabolism Journal, 2013, v. 37, n. 3, p. 181, doi. 10.4093/dmj.2013.37.3.181
    By:
    • Hye Jin Yoo;
    • Keun Yong Park;
    • Kang Seo Park;
    • Kyu Jeung Ahn;
    • Kyung Wan Min;
    • Jeong Hyun Park;
    • Sang Ah Chang;
    • Bong Soo Cha;
    • Dong-Jun Kim;
    • Yong Seong Kim;
    • Tae Keun Oh;
    • Suk Chon;
    • Il Seong Nam-Goong;
    • Mi Jin Kim;
    • Hye-Soon Kim;
    • Young Sik Choi;
    • You Hem Ahn;
    • Sora Leev;
    • Sei Hyun Baik
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors.

    Published in:
    Advances in Therapy, 2023, v. 40, n. 11, p. 4817, doi. 10.1007/s12325-023-02632-9
    By:
    • Oh, Jaewon;
    • Kim, Wonho;
    • Kim, Gee-Hee;
    • Kim, Hack-Lyoung;
    • Park, Sang-Don;
    • Min, Kyung Wan;
    • Hyun, Dongkeun;
    • Hong, Jun Hwa;
    • Lim, Soo;
    • Shin, Jinho;
    • Yoo, Byung Su;
    • Choi, Jong Hwan;
    • Park, Sangwon;
    • Cho, Yong Guk;
    • Lee, Sunil;
    • Shin, Dong Hoon;
    • Cha, Kwang Su;
    • Shim, Jaemin;
    • Kim, Young‑dae;
    • Park, Kyung-il
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50